Published in Health Business Week, June 19th, 2009
EPO's ratings and Stable Outlook are based on the quality and diversity of the underlying asset base and resulting cash flow performance, the impact of recently completed projects, EPO's attempts to partially mitigate commodity price risk, and a supportive sponsor. Fitch estimates consolidated 2009 Debt/EBITDA of 3.7 times (x) and EBITDA interest coverage...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.